This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Feb 1;116(2):251-252.

doi: 10.1093/cvr/cvz184.

Beating (T-lymphocyte driven) atherosclerosis with B- and T-lymphocyte attenuator

Meritxell Nus¹, Ziad Mallat^{1

2}, Andrew Sage¹

Affiliations

Affiliations

¹ Division of Cardiovascular Medicine, Department of Medicine, Box 157 Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
² Institut National de la Santé et de la Recherche Médicale (Inserm), Unit 970, Paris Cardiovascular Research Center, Paris, France.

PMID: 31297503
DOI: 10.1093/cvr/cvz184

Editorial

Beating (T-lymphocyte driven) atherosclerosis with B- and T-lymphocyte attenuator

Meritxell Nus et al. Cardiovasc Res. 2020.

. 2020 Feb 1;116(2):251-252.

doi: 10.1093/cvr/cvz184.

Authors

Meritxell Nus¹, Ziad Mallat^{1

2}, Andrew Sage¹

Affiliations

¹ Division of Cardiovascular Medicine, Department of Medicine, Box 157 Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
² Institut National de la Santé et de la Recherche Médicale (Inserm), Unit 970, Paris Cardiovascular Research Center, Paris, France.

PMID: 31297503
DOI: 10.1093/cvr/cvz184

No abstract available

PubMed Disclaimer

Comment on

B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells.
Douna H, Amersfoort J, Schaftenaar FH, Kröner MJ, Kiss MG, Slütter B, Depuydt MAC, Bernabé Kleijn MNA, Wezel A, Smeets HJ, Yagita H, Binder CJ, Bot I, van Puijvelde GHM, Kuiper J, Foks AC. Douna H, et al. Cardiovasc Res. 2020 Feb 1;116(2):295-305. doi: 10.1093/cvr/cvz129. Cardiovasc Res. 2020. PMID: 31150053

Similar articles

B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells.
Douna H, Amersfoort J, Schaftenaar FH, Kröner MJ, Kiss MG, Slütter B, Depuydt MAC, Bernabé Kleijn MNA, Wezel A, Smeets HJ, Yagita H, Binder CJ, Bot I, van Puijvelde GHM, Kuiper J, Foks AC. Douna H, et al. Cardiovasc Res. 2020 Feb 1;116(2):295-305. doi: 10.1093/cvr/cvz129. Cardiovasc Res. 2020. PMID: 31150053
The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis.
Antunes RF, Kaski JC, Dumitriu IE. Antunes RF, et al. J Biomed Biotechnol. 2012;2012:464532. doi: 10.1155/2012/464532. Epub 2011 Dec 22. J Biomed Biotechnol. 2012. PMID: 22235167 Free PMC article. Review.
Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus.
Zhang M, Howard K, Winters A, Steavenson S, Anderson S, Smelt S, Doellgast G, Sheelo C, Stevens J, Kim H, Hamburger A, Sein A, Caughey DJ, Lee F, Hsu H, Siu G, Byrne FR. Zhang M, et al. Clin Exp Immunol. 2011 Jan;163(1):77-87. doi: 10.1111/j.1365-2249.2010.04259.x. Epub 2010 Nov 16. Clin Exp Immunol. 2011. PMID: 21078085 Free PMC article.
B lymphocyte activation by contact-mediated interactions with T lymphocytes.
Bishop GA, Hostager BS. Bishop GA, et al. Curr Opin Immunol. 2001 Jun;13(3):278-85. doi: 10.1016/s0952-7915(00)00216-8. Curr Opin Immunol. 2001. PMID: 11406358 Review.
T and B lymphocytes. Exclusive role as responders and stimulators in human one-way mixed lymphocyte reaction.
Han T, Dadey B. Han T, et al. Immunology. 1976 Oct;31(4):643-8. Immunology. 1976. PMID: 135726 Free PMC article.

See all similar articles

Cited by

Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective.
Murray EC, Nosalski R, MacRitchie N, Tomaszewski M, Maffia P, Harrison DG, Guzik TJ. Murray EC, et al. Cardiovasc Res. 2021 Nov 22;117(13):2589-2609. doi: 10.1093/cvr/cvab330. Cardiovasc Res. 2021. PMID: 34698811 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program